Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007
Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007
Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010
Sequential nebulized salbutamol therapy in patients of acute bronchial asthma and its effect on serum potassium level Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005
Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Effects of ghrelin administration in cachectic patients with COPD Source: Annual Congress 2010 - Research development in exercise and gas exchange Year: 2010
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
Plasma biomarker assay and the immuno-modulatory effect of erythromycin in COPD Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009
Effects of ciclesonide on lung function and cortisol excretion in adolescent asthma patients – a comparative study with budesonide Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Evaluation of serum troponin level in exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011